How homoeopathy is regulated in India: laws and standards, a review

Knowing how a system of medicine is regulated helps patients ask better questions. This review summarises how the Ministry of Ayush describes the oversight of homoeopathy in India, based on its published figures and on its research council's own pages. Regulation covers training, registration, drug quality and advertising. It is a different matter from proof that a treatment works.

1. Introduction

Homoeopathy is one of the Ayush systems of medicine in India. Different bodies look after different parts of it, so there is no single office that does everything. The main areas are education and registration of practitioners, research, drug standards and drug law ^{[1, 2]}. The same Ministry lists homoeopathy among the Ayush systems of medicine ^[1].

It also helps to remember that these laws and bodies exist to maintain standards. A registered practitioner is expected to follow ethical rules, a licensed manufacturer is expected to follow quality rules, and a research council is expected to follow research standards. When one part of this chain is missing, for example an unregistered practitioner or an unlicensed medicine seller, the protection is weaker. Patients can therefore play a part by asking simple questions about registration and licences.

2. The National Commission for Homoeopathy

The Ministry of Ayush reports that the National Commission for Homoeopathy (NCH) Act, 2020 received presidential assent on 20 September 2020 and was published in the Gazette on 21 September 2020. It replaced the Homoeopathy Central Council Act, 1973, and the Commission began functioning on 5 July 2021 ^[1].

The stated objectives of the Commission include ^[1]:

• improving access to homoeopathy education
• maintaining a Homoeopathy Medical Register of practitioners
• assessing institutions from time to time
• enforcing ethical standards
• providing a way to settle grievances

Note that some older government web pages still mention the 1973 Act, which the 2020 Act replaced ^{[1, 4]}.

3. Drug standards and the pharmacopoeia

A pharmacopoeia is an official book of quality standards for medicines. The Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) develops the standards for homoeopathy, and its work is grounded in Rules 163A to 163G of the Drugs Rules, 1945. It also serves as the central drug testing and appellate (appeal) laboratory for Indian systems of medicine and homoeopathy ^[1]. The Ministry reports that monographs covering 1,117 homoeopathic drugs have been published in Volumes I to X ^[1].

CCRH also takes part in this area. Its work includes drug standardisation, drug proving (studying a substance's effects in healthy volunteers) and clinical verification, and it undertakes addition and revision of drugs in the Homoeopathic Pharmacopoeia of India ^[2].

4. Drug law and advertising

The Ministry's Drug Policy Section administers the Drugs and Cosmetics Act, 1940 and the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 for Ayurveda, Siddha, Unani and homoeopathy drugs ^[1]. As on 1 April 2024 there were 362 homoeopathy drug manufacturing units in the country ^[1].

The existence of an advertising law is a reminder that not every claim in an advertisement can be taken at face value. Be careful with any advertisement that promises a quick result or a sure outcome for a disease.

5. Research and its oversight

CCRH was formally constituted on 30 March 1978 as an autonomous organisation and began working independently in January 1979 ^[2]. Its stated mission includes setting standards of homoeopathic research in line with Good Clinical Practices-India and devising ways to integrate and mainstream homoeopathy in the national health care system ^[2]. Special committees oversee its technical work, including those for clinical research, drug proving, drug standardisation, fundamental research, ethics and scientific advice ^[2].

The Ministry also supports Extra Mural Research in homoeopathy through grant-in-aid, with CCRH scrutinising the projects received. The scheme aims to ascertain the efficacy of treatment, to improve understanding of homoeopathic principles and to validate the safety, efficacy and quality of Ayush drugs ^[3]. These are aims of the programme. They do not by themselves show what the studies have found.

6. Education and practitioners

The Ministry reports that, as on 1 April 2024, there were 273 undergraduate and 79 postgraduate homoeopathy colleges. As on 1 January 2024 there were 3,44,443 registered practitioners, of whom 2,96,878 were institutionally qualified ^[1]. The difference between these two numbers is a good reason to ask about a practitioner's qualification and registration before treatment.

7. What this means for patients

• Ask where the practitioner trained and whether they are on the state or national register.
• Buy medicines from licensed outlets and check the label for the manufacturer, batch and expiry date.
• Treat promises of sure results with caution. Regulation sets standards, but it is not a promise of results.
• Tell your doctor about every medicine you use, so interactions and delays in care can be avoided.

8. When to see a doctor

See a doctor promptly if symptoms are severe, getting worse, lasting or worrying, or if a child, a pregnant woman or an older person is unwell. Do not wait for a homoeopathic medicine to work before seeking a medical review, and do not stop prescribed medicines without medical advice.

In an emergency, call your local emergency number (112 in India, 911 in the United States).

9. Conclusion

India has a layered system for homoeopathy: a national commission for education and registration, a pharmacopoeia body for drug standards, drug and advertising laws, and a research council. These rules support quality and ethical practice, but they do not decide whether a treatment works for a given condition. Use registered practitioners and keep your doctor informed.